We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.62B
AUM Growth
+$177M
Cap. Flow
-$113M
Cap. Flow %
-1.71%
Top 10 Hldgs %
15.47%
Holding
879
New
57
Increased
333
Reduced
336
Closed
64

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$33.1M
2
AVA icon
Avista
AVA
+$21.5M
3
MGLN
Magellan Health Services, Inc.
MGLN
+$13.7M
4
ABT icon
Abbott
ABT
+$12.8M
5
ALE
Allete
ALE
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.55%
2 Technology 16.34%
3 Financials 14.72%
4 Industrials 10.4%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
276
Coca-Cola
KO
$380B
$5.02M 0.08%
98,656
-9,445
-9% -$463K
CNDT icon
277
Conduent
CNDT
$251M
$4.97M 0.08%
518,042
+165,584
+47% +$1.79M
PEGA icon
278
Pegasystems
PEGA
$4.85B
$4.93M 0.07%
138,500
+57,000
+70% +$2.03M
UEIC icon
279
Universal Electronics
UEIC
$58.1M
$4.93M 0.07%
120,098
-3,462
-3% -$139K
MDT icon
280
Medtronic
MDT
$111B
$4.92M 0.07%
50,571
+608
+1% +$55.5K
T icon
281
AT&T
T
$169B
$4.84M 0.07%
191,115
-26,197
-12% -$628K
WPX
282
DELISTED
WPX Energy, Inc.
WPX
$4.82M 0.07%
418,874
+407,861
+3,703% +$5.07M
PH icon
283
Parker-Hannifin
PH
$125B
$4.78M 0.07%
27,924
-3,161
-10% -$545K
CIM
284
Chimera Investment
CIM
$1.06B
$4.73M 0.07%
83,503
+644
+0.8% +$36.5K
IWM icon
285
iShares Russell 2000 ETF
IWM
$80.4B
$4.73M 0.07%
30,383
+42
+0.1% +$6.47K
NEO icon
286
NeoGenomics
NEO
$1.74B
$4.71M 0.07%
214,580
-18,009
-8% -$395K
OMCL icon
287
Omnicell
OMCL
$1.96B
$4.65M 0.07%
54,067
-3,306
-6% -$269K
RNST icon
288
Renasant Corp
RNST
$4.05B
$4.58M 0.07%
127,352
+19,801
+18% +$697K
QQEW icon
289
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.72B
$4.57M 0.07%
68,481
+765
+1% +$49.9K
CHD icon
290
Church & Dwight Co
CHD
$23.7B
$4.56M 0.07%
62,443
-3,345
-5% -$249K
BMY icon
291
Bristol-Myers Squibb
BMY
$130B
$4.55M 0.07%
100,186
-4,613
-4% -$215K
APD icon
292
Air Products & Chemicals
APD
$65.2B
$4.53M 0.07%
19,995
-100
-0.5% -$20.7K
CAT icon
293
Caterpillar
CAT
$387B
$4.53M 0.07%
33,182
+103
+0.3% +$13.6K
CUZ icon
294
Cousins Properties
CUZ
$5.22B
$4.51M 0.07%
+124,816
New +$4.69M
RLH
295
DELISTED
Red Lions Hotel Corporation
RLH
$4.47M 0.07%
628,780
+176,827
+39% +$1.36M
SRI icon
296
Stoneridge
SRI
$208M
$4.44M 0.07%
140,895
+3,143
+2% +$93K
BNY
297
Bank of New York Mellon
BNY
$106B
$4.42M 0.07%
100,329
-4,679
-4% -$220K
CHH icon
298
Choice Hotels
CHH
$5.22B
$4.38M 0.07%
+50,354
New +$4.2M
ADI icon
299
Analog Devices
ADI
$178B
$4.3M 0.06%
38,099
+5,569
+17% +$603K
RSP icon
300
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
$4.28M 0.06%
39,637
-673
-2% -$71.3K

Similar funds

Segall Bryant & Hamill's Q2 2019 Portfolio in Review

As of Q2 2019, Segall Bryant & Hamill held 879 positions worth $6.62B, up 2.7% from $6.44B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2019 filing shows 57 new, 333 increased, 336 reduced and 64 closed positions. Its largest new stake was Alcon: 564,559 shares worth $35M. The largest sale was LKQ Corp, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Segall Bryant & Hamill's largest Q2 2019 buy was Alcon: 564,559 shares worth $35M.
  • Segall Bryant & Hamill added most to Magellan Health Services, Inc. in Q2 2019, an estimated $13.7M increase.
  • Segall Bryant & Hamill's biggest Q2 2019 reduction was LKQ Corp, cutting an estimated $21.2M.
  • Segall Bryant & Hamill fully exited The GEO Group in Q2 2019, selling an estimated $13.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $6.62B portfolio in Q2 2019.
  • Segall Bryant & Hamill opened 57 new positions and closed 64 in Q2 2019.
  • Segall Bryant & Hamill's portfolio value rose 2.7% quarter-over-quarter to $6.62B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2019, filed 14 Aug 2019.